Abstract
Acute tonsillitis remains one of the common childhood diseases in developing countries. Prompt and appropriate treatment based on the knowledge of the causative microbiota and their antimicrobial susceptibility pattern will improve the treatment outcome and reduce time and resources spent on treatment. This study aims to determine the pattern of microbiota isolates and their susceptibility pattern. The study was a combination of the retrospective and cross-sectional method. The medical records of children treated for tonsillitis were retrieved, as well as those of children who presented with acute tonsillitis for the study. Interviewer-administered questionnaire was used to collect data, as well as document information retrieved from their medical record: presenting symptoms, treatments received. Swab sample was taken for culture and antibiotic susceptibility test. Out of the 72 swab cultures, 29 (40.3%) yielded insignificant growth of gram positive cocci. A total of nine (9) different isolates were obtained from all the significant swab cultures. Streptococcus species (13, 18.6%) and staphylococcus species (11, 15.3%) were the commonest isolates. Imipenem and levofloxacin revealed high level of susceptibility, while Ampicillin and Cefexine recorded high resistance rates. The proportion of the cultures that were positive of significant growth, the proportion of these positive isolates that were Streptococcus spp. and varied sensitivity pattern obtained underpinned the importance to advocate for culture isolates and susceptibility pattern guided treatment. These will not only an efficient approach to management of acute tonsillitis, but also a strong approach towards effective implementation of antibiotic stewardship.
Subject terms: Microbiology, Diseases, Medical research
Introduction
Acute tonsillitis in children is an extensive inflammatory upper respiratory tract infection associated with the inflammation of the lymphoid tissue of the palatine tonsillar. It is also referred to as tonsillopharyngitis, meaning essentially lesion of the oropharyngeal lymphoid ring and not restricted to only the tonsils. When the infection has lasted for just a short period of time it is acute tonsillitis1. Acute tonsillitis is uncommon in children under 1–1.5 years of age, because the maturation and completion of the tonsillar ring’s lymphoid tissue occurs after that age. The etiology in children under 3–4 years of age, are mainly viral or virobacterial etiology (adenoviruses, Coxsackie enteroviruses etc.) in about 95% of cases. The group A β-hemolytic streptococcus (Streptococcus pyogenes, GABHS) becomes significant in the causative organisms of acute tonsillitis in children over 4 years of age until the age of 18 years2,3. Recently, conjugated pneumococcal vaccine was introduced in the routine immunization programme of Nigeria. This vaccine promised to cover for the Streptococcal pneumonia which causes most of the upper respiratory tract infections and pneumonia.
Timely and correct diagnosis of streptococcal tonsillitis and further adequate antibacterial treatment can lead to prevention of acute rheumatic fever and purulent complications4, as well as renal complications. Like in other disease control programme, the laboratory confirmation of disease condition before treatment is pivotal5–8, and feasibility if rapid diagnostic test (RDT) is available9,10. But for diseases like Acute Tonsillitis which can be caused by multiple organisms, the lack of rapid diagnostic kit for these common organisms makes implementation of prompt laboratory diagnostic difficult especially in resource poor countries.
Culture examination of the ill child’s oropharyngeal swab can reveal the etiologic agent of tonsillitis and it is the gold standard. Systemic antibacterial therapy is most appropriate in the treatment of complicated tonsillitis especially with abscess, and evidence of streptococcal etiology of the inflammatory process11. Unfortunately, it is not a common practice in the African sub-region to wait for culture isolates and antibiogram before commencing antibiotic treatment. With the current ease in excluding malaria cases with MRDT12,13, and the ease of clinically detecting inflamed, enlarged and exudative tonsils or discharging ears, the empirical treatment of tonsillitis, using antibiotics stands to increase. Due to the abundant sensitive innervation of the pharyngeal mucosa, any pathological processes are accompanied with barrage of symptoms include pain14 and paediatricians and otorhynolaryngologists are compelled to treat empirically15,16. Despite evidence that microorganisms that causes acute tonsillitis are constantly changing both as isolates and even within isolates, their susceptibility to antibiotics varies17–19.
Profiling of isolates and their antibiotic susceptibility, will guide decision to treat and the choice of empirical antibiotics to use. This study aims to determine the prevalence of bacterial isolates in the childhood tonsillitis, and their antibiotic susceptibility.
Methods
Study area and population
The study was conducted in the children outpatient clinics of University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu State, and Federal Medical Center, Umuahia, Abia State, both in Southeast Nigeria. The UNTH, is a tertiary health facility located at Ituku/Ozalla, Enugu State, Southeast Nigeria. Enugu State has a population of approximately 3.3 million people20, according to national census of 2006. The children under 14 years make up 41 percent of the entire population21. There are laboratories that carry out different investigations and pharmacy that dispense drugs.
Federal medical Center, Umuahia is a tertiary health institution located in Umuahia, the capital of Abia state. The children out-patient clinic of the hospital renders service 5 days in a week. The hospital has well-equipped laboratories, among which is a microbiology laboratory.
Study design
The study was a combination of both retrospective and cross-sectional approach on cases of acute tonsillitis who presented to the clinic recruited.
Sample size calculation
The Epi-Info software was used to calculate the sample size. The Epi-Info version 722 was used to estimate the minimum sample size. This was based on the input of the prevalence of childhood tonsillitis of 11%23 and 95% confidence interval and power of 80%. The subjects were consecutively recruited as they attend the clinics. The sample size were calculated using the formula for bioequivalents and prevalence of acute tonsillits of 11%. N = Z2 p(1 – p)/d2 where N = is the size of sample for each group of treatment, Z2 is standard normal variate at 5% type 1 error (P < 0.05) and is equivalent to = 1.96, p = expected proportion in the population based on previous study of prevalence of 11%, d = absolute error or precision of 5% (0.05). Therefore, N = (1.96)2 * 0.11(1 – 0.11)/(0.05)2 = 150 children with acute tonsillitis. To recruit the sample size, all the children that present to children out-patient clinics with fever, whose caregiver gave consent to be part of the study were recruited. A total of 172 children with tonsillitis were recruited. The questionnaire was pre-tested and, ambiguous questions modified for clarity.
Data collection
The medical records of children managed for either tonsillitis over the period of 5 years from January 2014 to December, 2019 were retrieved and reviewed. The information on their age, gender, place of resident, household sizes, presenting symptoms, health seeking behaviors and treatment received were documented in a questionnaire. Children with enlarged, inflamed and exudative tonsils, and or ear discharge, who presented to children out-patient clinics from March 2019 to September 2019 had their throat swab taken for microscopy, culture and sensitivity.
Sample collection
The oral cavity of the child was opened widely, illuminated adequately with a head lamp, and the tongue depressed with a sterile wooden specular. The sterile swab stick was rubbed firmly on the surfaces of the inflamed tonsils, avoiding contact with the tongue or buccal mucosal.
Sample culture and identification
Samples were cultured on Chocolate agar, Blood agar and MacConkey agar plates by streaking method and incubated at 37 °C for 24 h aerobically and in CO2 reduced atmosphere. The plates were then examined for microbial growth. All isolates were identified using their growth morphology on culture media, haemolysis, Gram’s staining, and motility test and biochemical identification. All Gram negative rods were further identified biochemically on Lactose fermentation, Oxidase utilization, Catalase, Methyl red, Indole, Citrate, Urease, Nitrate reduction, Pigmentation, H2S production, Gelatin hydrolysis and capsule formation. Likewise, all isolates that were Gram positive were further identified on Haemolysis, Spore formation, Catalase, Coagulase, CAMP test, Bile solubility, Optochin sensitivity and Bacitracin sensitivity as in Cheesebrough et al.24.
Sensitivity test
The antibiotic Sensitivity tests were performed on the pathogenic isolates by Kirby Bauer disc diffusion technique using 0.5 McFarland standard. This was done using Muellar Hinton agar media17,25,26. Using aseptic technique, 3–5 discrete colonies of the microbial growth were suspended in about 2 ml of sterile normal saline and vortex to obtain smooth suspension. The turbidity was adjusted to 0.5 McFarland standard. Using cotton tipped sterile swab stick the surface of the Mueller Hinton agar was inoculated. Sterile forceps were used to manually place the antibiotic discs on the culture plates and incubated at 37 °C for 18 h. The zones of inhibition were measured using metric ruler a few inches above a black non-reflecting surface and measurements were compared with standard tables using the Committee for Clinical Laboratory Standards Institute26. The choice of antibiotics was based on commonly used antibiotics obtained from review of medical records and the feasible combination available in the antibiogram kit. Sensitivity was based on observed standard clearance around the antibiotic disc26. Direct microscopy was done using the isolates from the culture media27.
The culture and sensitivity was done at the Microbiology laboratory of University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu. The samples collected from Federal Medical Center, Umuahia, were put in ice pack and later refrigerated and sent in batches every 2 days (Wednesday and Fridays). Samples were not collected on Fridays, Saturdays and Sunday.
Data analysis
The data was entered and analyzed using SPSS version 20. Frequencies were calculated. Yates correction was used in variables with less than value of 0.05 to determine the significant.
Ethical consideration
The approval for the study was obtained from Health Research and Ethics Committee of University of Nigeria Teaching Hospital, Ituku-Ozalla. The Ethical Clearance Certificate number was NHREC/05/01/2008B-FWA00002458-1RB00002323. Issued on 1st April 2019. The Institutional reference number was UNTH/CSA/329/OL.5. All methods were performed in accordance with the relevant guidelines and regulations as described in the Helsinki Declaration. Information about the study was explained to the parents/caregivers of these children and written informed consent was obtained before recruiting them into the study. The results of the swab microscopy and sensitivity were held in confidentiality. The children were commenced on empirical antibiotics, which were later reviewed with the sensitivity results for the positive isolates.
Consent to participate
Written informed consent was obtained from all participants involved in the study. Information about the study was explained to the parents/caregivers of these children. The results of the swab microscopy and sensitivity were held in confidentiality. The children were commenced on empirical antibiotics, which were later reviewed with the sensitivity results for the positive isolates.
Results
There were 91 (52.9%) males involved in the study. Their median age was 2 years. Their median duration of onset of symptoms was 4 days. Majority 124 (72.1%) sought for care before presenting to the hospital. See Table 1.
Table 1.
Variables | n | % |
---|---|---|
Gender (n = 172) | ||
Male | 91 | 52.9 |
Female | 81 | 47.1 |
Age (in years) | ||
Mean | 3.8 years | |
Median | 2 years | |
Duration of illness (in days) | ||
Median | 4 days | |
Sought for care (n = 172) | ||
Yes | 124 | 72.1% |
No | 48 | 27.9% |
Previous episode(s) of Tonsillitis | ||
Yes | 24 | 14% |
No | 148 | 86% |
Informant (n = 172) | ||
Mother | 151 | 87.60% |
Father | 11 | 6.20% |
Grandmother | 4 | 2.30% |
Aunt | 2 | 1.20% |
Others | 5 | 2.70% |
Mothers' education (n = 151) | ||
None | 0 | 0% |
Primary | 2 | 1.30% |
Secondary | 26 | 17.20% |
Tertiary | 123 | 81.50% |
Mothers' occupation (n = 144) | ||
Civil servant | 45 | 31.30% |
Business | 25 | 17.40% |
Housewife/unemployed | 23 | 16% |
Teacher | 19 | 13.20% |
Nurse | 7 | 4.80% |
Petty trader | 4 | 2.80% |
Others | 21 | 14.50% |
The proportion of the subjects that received antibiotics and antimalarial before presenting to the hospital were about 47 (35.6%) and 51 (38.7%) respectively. Cough a respiratory system symptom and vomiting a digestive system symptom were the commonest with prevalence of 74 (43%) and 35 (20.3%) respectively. See Table 2.
Table 2.
Pre-medications | n = 132 | % | Presenting symptoms | n = 172 | % |
---|---|---|---|---|---|
Antibiotics | General | ||||
Amoxicilli/Ampicillin | 21 | 15.90% | Fever | 127 | 73.80% |
Augumentin/Co-amoxiclav | 26 | 19.70% | Weakness | 7 | 4.10% |
Azithromycin | 3 | 2.30% | Respiratory | ||
Cefexine | 2 | 1.50% | Cough | 74 | 43% |
Ceftriaxone | 2 | 1.50% | Catarrh | 45 | 26.20% |
Cefuroxine | 4 | 3% | Ear Pain | 12 | 7% |
Ciprofloxacin | 1 | 0.8 | Ear discharge | 12 | 7% |
Cotrimoxazole/Septrin | 4 | 3% | Noisy breathing | 11 | 6.40% |
Erythromycin | 5 | 3.90% | Sore throat | 9 | 5.20% |
Metronidazole | 4 | 3% | Mouth breathing | 4 | 2.30% |
Orelox/Cefpodoxine | 7 | 5.30% | Difficult breathing | 3 | 1.70% |
Antimalarial | Digestive | ||||
ACTs | 41 | 31.10% | Vomiting | 35 | 20.30% |
Artemisinin Monotherapy | 10 | 7.60% | Throat pain | 27 | 15.70% |
Camoquine | 3 | 2.30% | Loose stool | 17 | 9.90% |
Chloroquine | 1 | 0.00% | Loss of appetite | 14 | 8.10% |
Abdominal pain | 8 | 4.70% | |||
Salivation | 3 | 1.70% | |||
Mouth dour | 1 | 0.60% | |||
Antipyretics | Central nervous | ||||
Ibuprofen | 19 | 14.40% | Convulsion | 6 | 3.50% |
Paracetamol | 34 | 25.80% | Headache | 5 | 2.90% |
Excessive cry | 1 | 0.60% | |||
Other medications | Others | ||||
Cough syrup | 18 | 13.60% | Pains | 10 | 5.80% |
Vitamin C | 6 | 4.50% | Rash | 5 | 2.90% |
Astymin | 3 | 2.30% | Swelling | 2 | 1.20% |
Multivite | 1 | 0.80% | Eye discharge | 1 | 0.60% |
Most 29 (40.3%) of the swab culture yielded insignificant growth of gram positive cocci. A total of nine (9) different isolates were obtained from the swab culture. Among the significant isolates were streptococcus species (13, 18.6%) and staphylococcus species (11, 15.3%). See Fig. 1.
Imipenem (45, 95.7%) and Levofloxacin (37, 78.7%) had the highest sensitivity across all the isolates put together. Ceftriaxone, Azithromycin, and Amoxicillin/Clavulanic acid had sensitivity of 68.1% (32), 57.4% (27) and 42.6% (20) respectively. The least sensitive antibiotics were ampicillin 8 (17%) and Cefexine 17 (36.3%). See Table 3.
Table 3.
Isolates | Sensitivity pattern | Imipenem | Levofloxacin | Ceftriaxone | Azithromycin | Amoxicillin-Clavulanic | Cefexine | Ampicillin |
---|---|---|---|---|---|---|---|---|
Staphylococcus aureus (n = 11) | Sensitive | 9 | 11 | 7 | 6 | 8 | 8 | 4 |
Resistant | 2 | 0 | 4 | 5 | 3 | 3 | 7 | |
Streptococcus species (n = 13) | Sensitive | 13 | 11 | 13 | 9 | 5 | 4 | 2 |
Resistant | 0 | 2 | 0 | 4 | 8 | 9 | 11 | |
Proteus (n = 10) | Sensitive | 10 | 7 | 3 | 5 | 2 | 2 | 0 |
Resistant | 0 | 3 | 7 | 5 | 8 | 8 | 10 | |
Klebsiella (n = 5) | Sensitive | 5 | 3 | 3 | 3 | 0 | 0 | 0 |
Resistant | 0 | 2 | 2 | 2 | 5 | 5 | 5 | |
Pseudomonas (n = 5) | Sensitive | 5 | 4 | 3 | 1 | 2 | 2 | 1 |
Resistant | 0 | 1 | 2 | 4 | 3 | 3 | 4 | |
Morexella catalalis (n = 2) | Sensitive | 2 | 0 | 2 | 2 | 2 | 0 | 0 |
Resistant | 0 | 2 | 0 | 0 | 0 | 2 | 2 | |
E. coli (n = 1) | Sensitive | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Resistant | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Summed sensitivity | 45 (95.7%) | 37 (78.7%) | 32 (68.1%) | 27 (57.4%) | 20 (42.6%) | 17 (36.3%) | 8 (17%) | |
Summed resistant | 2 | 10 | 15 | 20 | 27 | 30 | 39 |
Amoxicillin/Clavulanic acid (26, 19.7%) and Amoxicillin or Ampicillin (21, 15.9%) were the commonly used drugs before hospital presentation. See Table 2.
The proportion of paediatric who presented with the first episode of tonsillitis with positive bacterial isolates were higher (44, 29.7%) than in those with recurrent episode(s) of tonsillitis (3, 12.5%), but it was not a statistically significant difference (p value = 0.079). See Table 4.
Table 4.
Episodes of tonsillitis | χ2 | p value | ||
---|---|---|---|---|
First episode | Had previous episode(s) | |||
Positive bacterial isolate(s) | 44 (29.7%) | 3 (12.5%) | 3.087 | 0.079 |
No bacterial isolate(s) | 104 (70.3%) | 21 (87.5%) |
Discussion
Majority 72.1%, of the parents/caregivers of these paediatrics with acute tonsillitis sought for care prior to presenting to tertiary health facility. It is a common practice for parents to try some medications which can be remaining drugs used for treatment in the previous illnesses28, or purchased from the drug retailers in the course of the present illness29. Among the major reason for seeking for health are symptoms suggestive of malaria, acute respiratory infections, and diarrhea as reported by Adegboyega et al.30 Most only seek for care from health facilities when the expected relief from self-treatment was not realized. This delay might explain the median duration of illness of 4 days obtained in this study. Extensive behavioral communication change campaign targeted towards mothers, should be deployed through all the contacts and avenues, as well as interventions that can reduce the barriers to access and utilization of services of healthcare facilities31.
Antibiotics and antimalarial usage prior to presentation were high. This practice has a dire consequences since studies have shown that varied proportion of treatment administered both at home and at facilities were faulty either in dosage or in timing32. This poor antibiotic practices could contribute to the poor susceptibility of the isolates to the commonly used antibiotics, which about a decade ago recorded good susceptibility to the same isolates33. In the study by Sadoh et al.33, Beta Hemolytic Streptococcus and Staphylococcus aureus showed 100% susceptibility to azithromycin, but in this study, the same organisms showed 70% and 54.5% respectively. A loss in sensitivity of 30% and 46.5% respectively in an interval of 14 years. Although Imipenem and Levofloxacin showed a good susceptibility. These are relatively new drugs, imipenem has no oral preparations and levofloxacin is not a commonly used drugs, so difficult to abuse in the community. Furthermore, some commonly used non-anti-psuedomonal drug like Azithromycin was included in the sensitivity because it is among the antibiotics commonly used in treatment of upper respiratory tract infection33–37. This observed change is of great concern with the new WHO report that very few antibiotics currently in development address the serious and growing threat of antimicrobial resistance to classes of priority pathogens identified by World Health Organization, according to the Global Antimicrobial Resistance Surveillance System (GLASS)38.
About 42.5% of the swab culture yielded no growth or insignificant growth of gram-positive cocci. This finding was similar to other studies that reported no isolates ranging from 46.6 to 75.6%33,39. This variation in culture yield could be attributed to the findings in a review by van der Veen et al.40 In their work, they found that a higher positive culture results (55%) were found in the swab taken from the posterior pharyngeal wall compared to 35% obtained from the swab taken from the tonsillar surface among children selected for adenotonsilectomy. Furthermore, it has been shown that variations in the microbial flora do essentially play a distinct role in the predisposition of children to tonsillar disease41. The proportion of isolates were Enterobacterieceae. The Enterobacterieceae is a large group of Gram-negative bacteria that includes pathogens like Klebsiella, Proteus and Escherichia coli among others, which is a normal part of the human intestinal tract (gut) flora, deserve explanation. Similarly, other studies have isolated these organisms from the oro-pharynx were among paediatrics42,43. This could be as a result of certain habits like; premastication of meat and other foods by adults for their children44 and general poor hygiene could predispose to being infected by these organisms. Thus clinicians need to evaluate the risks and benefits prior to prescribing immediate antibiotics for uncomplicated tonsillitis. History of recurrent episodes of acute tonsillitis, which is often the reason for performing surgical procedures in children, did not show any statistically significant difference in the prediction of positive swab culture isolate(s). Therefore each child should be evaluated individually, reviewing the presenting complaints, with swab investigation result, before prescribing antibiotic if it will be needed.
One envisaged challenge is the healthcare providers being under pressure to commence empirical treatment without knowledge on investigation result. In view of some challenges: laboratory result taking an average of 3 days for results to be ready, and parents travelled some distance to present to the health facility and will be anticipating some form of treatment. But study has shown that caregivers are willing to do investigation if prescribed by a physician45. Paediatricians and Ortorynolaryngologists need to realize that most of the parents/caregivers opt to use formal health care facilities when they have experienced failure with their previous self-medication. In this study, 72.1% of the parents/caregivers had received some form of treatment before presenting. Therefore, at the point they came for care, they are highly willing to get relief of their children symptoms. Notwithstanding, this claim, majority of the healthcare providers have the strong perception that parents/caregivers would expect their ill children to be commenced on treatment while awaiting for the outcome of the investigation, as noted by Britten et al.46 All parents/caregivers want prescriptions, basically on their anticipation of what will improve the health condition of their sick child, not particularly the content of the prescription. Therefore, healthcare providers can commence the child on symptomatic treatment/agents consist of topical preparations (slowly disintegrating tablets, sprays, lozenges, antiseptic containing mouthwashes like chlorhexidine, anesthetics like lidocaine, antibiotics, vitamins especially ascorbic acid and deodorants14. Only the most efficient and safe drugs will be recommended for children with uncomplicated cases on an out-patient basis until their swab test result is established. For patients with features of complications like abscess, they can be admitted on supportive care and for surgical evaluation, until the isolate(s) is/are confirmed and susceptibility pattern known. It therefore means that with appropriate supportive care, commencement of antibiotic treatment can be withhold for a while or rather till it is necessary. The delay in commencing definitive antibiotic treatment can be reduced if not entirely eliminated with deployment of group A Beta haemolytic streptococci rapid test kits47. The concern on default to follow if the child improved the symptomatic treatment does not really hold, since it has been shown that respondents are willing to return for the result of their tests and also for addition of more medication at a later date, even if their children have made remarkable improvement45. Efforts should also be made to explain treatment plan, so that in the event that their children improved on supportive care, they would not be compelled to carry over the same treatment in future re-occurrence of similar symptom(s). Considering the close similarity the symptoms of tonsillitis have with other illnesses that may be more sinister, as well as the complications of ill-managed streptococci tonsillitis: rheumatic fever, and renal complications48,49.
Limitations
This study has one major limitation that needs to be addressed in subsequent study. The inclusion of 47 (35.6%) of patients that were on antibiotics prior to the presentation and the culture has potential of affecting the interpretation of the results. However, if this group was dispersed in the entire subjects, it may reduce the percentage of positive yield but not the proportion of the cultured organisms. Although the persistence of symptoms and inflammation as at the time of presentation is an indication that the causative microbes are still present and active. Going forward future studies may require two separate groups: a group not on antibiotics and a second group of patients already on antibiotics, to be reported on. Another limitation is that the entire sample size of 172 children with acute tonsillitis recruited for the study, not all had throat swab taken for microscopy, culture and sensitivity, due to limited fund available for the study, and thus can affect the generalization of the findings to entire population of children with acute tonsillitis. However, the scope of the micro organisms isolated and their sensitivity pattern may not vary widely if large population survey was carried, but the prevalence of isolation of each of the micro organisms may vary. Therefore, a larger population survey may be required to establish this fact.
Conclusion
The proportion of the cultures that were positive of significant growth, the proportion of these positive isolates that were Streptococcus spp. and varied sensitivity pattern obtained underpinned the important to advocate for culture isolates and susceptibility pattern guided treatment. This is not only an efficient approach to management of acute tonsillitis, but also a strong approach towards effective implementation of antibiotic stewardship.
Acknowledgements
We are thank all the parents that allowed their children to participate in this study. We thank University of Nigeria, which provided funding for this study through the Tertiary Education Trust Fund (TETFund) Grant.
Author contributions
U.M.D. and A.J.O. conceptualized and designed the study and ensured its overall coordination. U.M.D. and O.O.H. developed and reviewed study tools. E.N., O.S., A.L., O.O.H., and M.N.G. were responsible for the overall data collection and laboratory investigations. U.N. reviewed and oversaw the antibiotic usage throughout the study. U.M.D. and O.O.H. were responsible for data management and analysis. The manuscript was drafted by U.M.D. and A.J.O. All authors made critical comments on the manuscript draft and approved the final version of the manuscript for submission and agreed to be responsible for all aspects of the work.
Funding
The study was funded by Tertiary Educational Trust Fund (TETFund) received through University of Nigeria Nsukka.
Data availability
More complete data are available from the authors upon request.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Kankasova MN, Mokhova OG, Pozdeeva OS. Prakticheskaya meditsina. Pract Med. 2009;7(39):55–62. [Google Scholar]
- 2.Ebell MH, Smith MA, Barry HC, Ives HC, Carey M. The rational clinical examination. Does this patient have strep throat? JAMA. 2000;284:2912–8. doi: 10.1001/jama.284.22.2912. [DOI] [PubMed] [Google Scholar]
- 3.Boccazzi A, Garotta M, Pontari S, Agostoni CV. Streptococcal tonsillopharyngitis: Clinical vs. microbiological diagnosis. Infez. Med. 2011;19(2):100–5. [PubMed] [Google Scholar]
- 4.Gieseker K, et al. Evaluating the American Academy Pediatrics diagnostic standard for Streptococcus pyogenes pharyngitis: Back up culture versus repeat rapid antigen testing. Pediatrics. 2003;111:666–670. doi: 10.1542/peds.111.6.e666. [DOI] [PubMed] [Google Scholar]
- 5.Snow RW, Marsh K. Malaria in Africa: Progress and prospects in the decades since the Abuja declaration. Lancet. 2010;376:137–139. doi: 10.1016/S0140-6736(10)60577-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.World Health Organization: African Summit on Roll Back Malaria. Abuja, Nigeria. WHO/CDS/RBM/2000.17. Geneva: WHO; 2000.
- 7.Tarimo, D. S., Minjas, J. N. & Bygbjerg, I. C., Malaria diagnosis and treatment under the strategy of the integrated management of childhood illness (IMCI): Relevance of laboratory support from the rapid immunochromatographic tests of ICT malaria P.f/P.v and OptiMal. Ann. Trop. Med. Parasitol.95, 437–443 (2001). [DOI] [PubMed]
- 8.Rolland E, Chechi F, Pinoges L, Balkan S, Guthmann JP, Guerin PJ. Operational response to malaria epidemics: Are rapid diagnostics test cost-effective? Trop. Med. Int. Health. 2006;11:398–408. doi: 10.1111/j.1365-3156.2006.01580.x. [DOI] [PubMed] [Google Scholar]
- 9.Moody A. Rapid diagnostic tests for malaria parasites. Clin. Microbiol. Rev. 2002;15:66–78. doi: 10.1128/CMR.15.1.66-78.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Makler MT, Palmer CJ, Ager AL. A review of practical techniques for the diagnosis of malaria. Ann. Trop. Med. Parasitol. 1998;92:419–433. doi: 10.1080/00034989859401. [DOI] [PubMed] [Google Scholar]
- 11.Polunin MM, Titarova LS, Polunina TV. Streptokokkovyiy tonzillit u detey [Streptococcal tonsillitis in children] Pediatr. Pharmacol. 2012;9(3):19–21. doi: 10.15690/pf.v9i3.317. [DOI] [Google Scholar]
- 12.Molineux C, Mung’ala-odera V, Harpham T, Snow RW. Maternal response to childhood fever: a comparison of rural and urban residents in Coastal Kenya. Tropical Medicine and International Health 1999;4:836–845. [DOI] [PubMed]
- 13.Tarimo DS, Lwihula GK, Minjas JN, Bygbjerg IC. Mothers’s perceptions and knowledge on childhood malaria in the holoendemic Kihaha district, Tanzania: Implication for malaria control and the IMCI strategy. Tropical Med. Int. Health. 2000;5:179–184. doi: 10.1046/j.1365-3156.2000.00537.x. [DOI] [PubMed] [Google Scholar]
- 14.Vetrova AD, Acute tonsillitis in children: a pediatricians perspective. Pediatric pharmacology 2014,11(2).10.15690/pf.v11i2.959
- 15.Gaffney RJ, Cafferrkey MT. Bacteriology of normal and deseased tonsils assessed by fine-needle aspiration: Haemophilus inflenzae and the pathogenesis of recurrent acute tonsillitis. Clin. Otolaryngol. 1998;23:181–185. doi: 10.1046/j.1365-2273.1998.00136.x. [DOI] [PubMed] [Google Scholar]
- 16.Richelle JC, Jerome RH, John GB, et al. Principle of appropriate antibiotic use for acute pharygnitis in adults. Ann. Intern. Med. 2001;134:6509–6517. [Google Scholar]
- 17.Babaiwa UF, Onyeagwara NC, Akerele JO. Bacterial tonsillar microbiota and antibiogram in recurrent tonsillitis. Biomed. Res. 2013;24(3):298–302. [Google Scholar]
- 18.Mahajan GD. Evaluation of antibiotic sensitivity pattern in acute tonsillitis. Int. J. Otorhinolaryngol. Head Neck Surg. 2018;4(5):1162–1166. doi: 10.18203/issn.2454-5929.ijohns20182953. [DOI] [Google Scholar]
- 19.Chole RA, Faddis BT. Anatomical evidence of microbial biofilms in tonsillar tissues. Arch. Otolaryngol. Head Neck Surg. 2003;129(6):634–636. doi: 10.1001/archotol.129.6.634. [DOI] [PubMed] [Google Scholar]
- 20.Federal Republic of Nigeria Official Gazette. Legal notice on publication of the details of the breakdown of the national and state provisional totals 2006 Census. http://www.nigerianstat.gov.ng/ansapps/Connections/Pop2006.pdf. Assessed April 13, 2013.
- 21.Nigeria Demographic Profile 2012. http://www.indexmundi.com/nigeria/demographic.profile.html. Assessed on April 13, 2013.
- 22.Center for Disease Control and Prevention, Atlanta, USA. CDC. http://www.cdc.gov.
- 23.Tesfaw G, Abdissa A. Prevalence of group A B haemolytic streptococcus among children with pharyngitis in Jimma town Southwest Ethiopia. Egypt. J. Ear Nose Throat Allied Sci. 2015;16(1):35–40. doi: 10.1016/j.ejenta.2015.02.001. [DOI] [Google Scholar]
- 24.Cheesebrough, M. District Laboratory Practice in Tropical Countries Part 2. 357 (Cambridge University Press, Cambridge, 2004).
- 25.Bauer AW, Kurby WM. Antibiotic susceptibility testing by standardized single disk method. Am. J. Clin. Pathol. 1966;45:493–496. doi: 10.1093/ajcp/45.4_ts.493. [DOI] [PubMed] [Google Scholar]
- 26.Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. Twenty first Informational Supplement CLSI 2011, 31(1).
- 27.Ingale MH, Mahajan GD. Evaluation of antibiotic sensitivity pattern in acute tonsillitis. Int. J. Otorhinolaryngol. Head Neck Surg. 2018;4:1162–1166. doi: 10.18203/issn.2454-5929.ijohns20182953. [DOI] [Google Scholar]
- 28.Salako LA, Brieger W, Afolabi BM, Akinlade OC. Treatment of childhood fevers and illnesses in three rural Nigerian communities. J. Trop. Pediatr. 2001;47(4):230–238. doi: 10.1093/tropej/47.4.230. [DOI] [PubMed] [Google Scholar]
- 29.Uzochukwu BSC, Onwujekwe EO, Onoka CA, Ughasoro MD. Rural–urban differences in maternal responses to childhood fever in south east Nigeria. PLoS One. 2008;3(3):e1788. doi: 10.1371/journal.pone.0001788. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Adegboyega AA, Onayade AA, Salawu O. Care-seeking behavior of caregivers for common childhood illnesses in Lagos Island Local Government Area, Nigeria. Niger. J. Med. 2006;14(1):65–71. doi: 10.4314/njm.v14i1.37138. [DOI] [PubMed] [Google Scholar]
- 31.Agyemang-Duah W, Peprah C, Peprah P. Barriers to formal healthcare utilization among poor older people under the livelihood empowerment against poverty programme in Atwima Nwabiagya District of Ghana. BMC Public Health. 2019;19:1185. doi: 10.1186/s12889-019-7437-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Rowe AK, Onikpo F, Lama M, Cokou F, Deming MS. Management of childhood illness at health facilities in Benin: Problems and their causes. Am. J. Public Health. 2001;91(10):1625–1635. doi: 10.2105/AJPH.91.10.1625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Sadoh WE, Sadoh A, Oladipo O, Okunola O. Bacterial isolates of tonsillitis and pharyngitis in a paediatric casualty setting. J. Med. Biomed. Res. 2008 doi: 10.4314/jmbr.v7i1-2-44555. [DOI] [Google Scholar]
- 34.Abdel-Naby Awad OG. Echinacea can help with Azithromycin in prevention of recurrent tonsillitis in children. Am. J. Otolaryngol. 2020;41(4):102344. doi: 10.1016/j.amjoto.2019.102344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Langtry HD, Balfour JA. Azithromycin. A review of its use in paediatric infectious diseases. Drugs. 1998;56(2):273–97. doi: 10.2165/00003495-199856020-00014. [DOI] [PubMed] [Google Scholar]
- 36.Rehan HS. Pattern of drug utilization in acute tonsillitis in a teaching hospital in Nepal. Indian J. Otolaryngol. Head Neck Surg. 2003;55(3):176–179. doi: 10.1007/BF02991947. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Lakoš AK, Pangerčić A, Gašparić M, Kukuruzović MM, Kovačić D, Baršić B. Safety and effectiveness of azithromycin in the treatment of respiratory infections in children. Curr. Med. Res. Opin. 2012;28(1):155–162. doi: 10.1185/03007995.2011.639355. [DOI] [PubMed] [Google Scholar]
- 38.World Health Organization. Antibiotic resistance 2018. https://www.who.int/
- 39.Santo AGP, Berezin EN. Comparative analysis of clinical and laboratory methods for diagnosing streptococcal sore throat. J. Pediatr. 2005;81(1):23–28. doi: 10.2223/1278. [DOI] [PubMed] [Google Scholar]
- 40.van der Veen EL, Sanders EAM, Videler WJM, van Staaii BK, van Benthem PPG, Schilder AGM. Optimal site for throat culture: GTonsillar surface versus Posterior Pharyngeal wall. Eur. Arch. Otorhinolaryngol. 2006;263(8):750–753. doi: 10.1007/s00405-006-0046-6. [DOI] [PubMed] [Google Scholar]
- 41.Van Staajj BK, Den Akker Van, Van Dorsser EHM, Fleer A, Hoes AW, Schilder AGM. Does the tonsillar surface flora differ in children with and without tonsillar disease? Acta Otolaryngol. 2003;123(7):873–8. doi: 10.1080/00016480310000395. [DOI] [PubMed] [Google Scholar]
- 42.Okoye EL, Obiweluozor CJ, Uba BO, Odunukwe FN. Epidemiological survey of tonsillitis caused by Streptococcus pyogenes among children in Awka metropolis (a case study of hospitals in Awka Community, Anambra State) J. Pharm. Biol. Sci. 2016;1:1–1. doi: 10.9790/3008-1103025458. [DOI] [Google Scholar]
- 43.El Galil SYA, El Gawad SA, El Ateeq E. Isolation and identification of microorganisms causing tonsillitis among children of Hail region. Int. J. Health Sci. Res. 2014;4(1):125–129. [Google Scholar]
- 44.Butler LM, Neilands TB, Mosam A, Mzolo S, Martin JN. A population-based study of how children are exposed to saliva in KwaZulu-Natal Province, South Africa: Implications for the spread of saliva-borne pathogens to children. Trop. Med. Int. Health. 2010;15(4):442–453. doi: 10.1111/j.1365-3156.2010.02474.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Ughasoro MD, Okoli CC, Uzochukwu BSC. Qualitative study of presumptive treatment of childhood malaria in third tier tertiary hospitals in southeast Nigeria: A focus group and in-depth study. Malar. J. 2013;12:436. doi: 10.1186/1475-2875-12-436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Britten N, Ukoumunne O. The influence of patients’ hopes of receiving aprescription on doctors’ perceptions and the decision to prescribe: A questionnaire survey. BMJ. 1997;315:1506–1510. doi: 10.1136/bmj.315.7121.1506. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Maria JF, Fontes FB, Maria TM, Fonseca LB, Lasmar RD, Augusto MC. Early diagnosis of streptococcal pharyngotonsillitis: Assessment by latex agglutination test. J. Pediatr. 2007;83(5):465–470. doi: 10.2223/JPED.1695. [DOI] [PubMed] [Google Scholar]
- 48.Del Mar CB, Glasziou PP, Spinks AB, Saliba WR, Mader R. Antibiotics for sore throat. Isr. Med. Assoc. J. 2000;2(6):433–437. [Google Scholar]
- 49.Sarrell EM, Giveon SM. Streptococcal pharyngitis: A prospective study of compliance and complications. ISRN Pediatr. 2012 doi: 10.5402/2012/796389. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
More complete data are available from the authors upon request.